NKGN

NKGen Biotech, Inc. Common Stock
NKGN

Overview Fund Activity
Delisted

NKGN was delisted on the 4th of March, 2025.

Back to rankings

25 hedge funds and large institutions have $65.3M invested in NKGen Biotech, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 11 reducing their positions, and 33 closing their positions.

Holders
25
Holders Change
-30
Holders Change %
-54.55%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
11
Closed
33
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SFM
1
Spartan Fund Management
Canada
$4.67M
2
FTCM
2
Fir Tree Capital Management
New York
$5.68M
3
WCMNY
3
Westchester Capital Management (New York)
New York
$1.09M
4
Walleye Capital
4
Walleye Capital
New York
$867K
5
VF
5
Virtu Financial
New York
$127K

Top Sellers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$0
2
PC
2
Periscope Capital
Ontario, Canada
$3.59M
3
AC
3
Aristeia Capital
Connecticut
$0
4
CIM
4
Cowen Investment Management
New York
$0
5
CSS
5
Cubist Systematic Strategies
Connecticut
$0
Name Market Value Shares Shares
Change 		Shares
Change %
DCM
51
Difesa Capital Management
New York
– – -53,117 Closed
COPPSERS
52
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
– – -50,000 Closed
BFM
53
Boothbay Fund Management
New York
– – -31,992 Closed
GCWM
54
Graham Capital Wealth Management
District of Columbia
– – -26,959 Closed
RCM
55
Robinson Capital Management
Michigan
– – -12,000 Closed
LCM
56
Landscape Capital Management
New Jersey
– – -11,337 Closed
DFCM
57
Dark Forest Capital Management
Puerto Rico
– – -3,824 Closed
UBS Group
58
UBS Group
Switzerland
– – -590 Closed
CFGS
59
Concourse Financial Group Securities
Alabama
– – – –
1 2
3